FoLix Named Best Laser Treatment for Hair Loss Two Years Running

Tatiana Bido, NewBeauty’s director of aesthetic content, called FoLix “a thoughtful in-office option for patients concerned about thinning hair.” And that’s a growing market. Around 85% of men¹ and 50% of women² will face hair loss. Hair thinning is a tangible experience, often undermining one’s confidence and sense of self, and many are desperate for it to stop, often turning to industry staples like minoxidil, LLLT, PRP, stem-cell serums, and more.

While it can be overwhelming for medical providers and patients to identify the most optimal solutions in such a crowded market, NewBeauty highlighted what sets FoLix apart: It harnesses FDA-cleared fractional laser energy to stimulate hair follicles without pills, injections, or invasive procedures. It’s a meaningful step forward for patients who want clinical results without the complexity.

NewBeauty’s selection process goes well beyond surface-level testing. Editors track launches and innovations year-round, reading white papers, analyzing clinical data, and interviewing experts. They also survey 150 board-certified dermatologists and plastic surgeons on the in-office treatments they consider most effective, from microneedling to fillers and beyond.

What makes FoLix a category leader?

Launched in the U.S. in September 2024, FoLix is built on non-ablative fractional laser (NAFL) technology and a suite of proprietary advancements tailored specifically for treating hair loss. Rather than a one-size-fits-all approach, FoLix delivers precise laser pulses that work with the body’s own healing processes, stimulating dormant follicles, improving blood flow, and encouraging tissue regeneration at the scalp level.

• Results in just 4 to 6 monthly sessions, with no chemicals, needles, anesthesia, surgery, or downtime
• Homogeneous micro-beam placement ensures optimal irradiance and consistent area coverage session after session
• Intuitive interface with FDA-cleared treatment settings for efficient, repeatable outcomes
• Patent-pending FoliCool™ tip actively cools the scalp during treatment, enhancing comfort and enabling faster, smoother application

The clinical evidence

FoLix’s performance is backed by a growing body of clinical research. Prospective studies* demonstrate measurable, statistically meaningful improvements in hair density following treatment, including a 10–18% increase in hair count and 13–16% increase in follicular units per cm².

A retrospective analysis** of 98 patients showed consistent improvement in scalp hair appearance after 4 to 6 laser treatments, with no adverse events reported. Three U.S. board-certified dermatologists reviewed the results, correctly identifying before-and-after images in 96.9% of cases.

Behind FoLix is the full weight of Lumenis’ decades of expertise in energy-based medical technology. This recognition reflects not just a single product, but a commitment to meaningful innovation. We develop solutions that genuinely improve the lives of the millions of people worldwide living with hair loss, giving both patients and providers the tools to move forward with confidence.